NASDAQ:BBH - VanEck Vectors Biotech ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VanEck Vectors Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $143.22 +0.75 (+0.53 %) (As of 02/16/2020 01:57 PM ET) Add Today's Range$142.09Now: $143.22▼$143.2650-Day Range$132.39MA: $138.99▼$143.2252-Week Range$113.89Now: $143.22▼$143.38Volume15,601 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Basic Details Issuer Van Eck Fund NameVanEck Vectors Biotech ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Fund Statistics Assets Under Management$1.92 billion Average Daily Volume$14,048.50 Discount/Premium-1.27% ETF Expenses Management Fee0.35% Other Expenses0.04% Total Expenses0.39% Fee Waiver-0.04% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianThe Bank of New York Mellon Corporation DistributorVan Eck Securities Corporation Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerVirtu Financial Receive BBH News and Ratings via Email Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:BBH Rates by TradingView VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions What is VanEck Vectors Biotech ETF's stock symbol? VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH." Has VanEck Vectors Biotech ETF been receiving favorable news coverage? News coverage about BBH stock has trended neutral recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. VanEck Vectors Biotech ETF earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for VanEck Vectors Biotech ETF. What other stocks do shareholders of VanEck Vectors Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Arlo Technologies (ARLO), International Game Technology (IGT), SPDR S&P 500 ETF Trust (SPY), Alliance MMA (AMMA), Ashford (AINC), Allied Healthcare Products (AHPI), Adobe (ADBE), B&M European Value Retail (BME), Anglo American (AAL) and Deutsche Bank (DBK). Who are VanEck Vectors Biotech ETF's major shareholders? VanEck Vectors Biotech ETF's stock is owned by many different of institutional and retail investors. Top institutional investors include UBS Group AG (1.81%), Murphy Capital Management Inc. (1.43%), Bank of America Corp DE (1.26%), Mogy Joel R Investment Counsel Inc. (0.93%), Jane Street Group LLC (0.79%) and Raymond James & Associates (0.58%). Which institutional investors are selling VanEck Vectors Biotech ETF stock? BBH stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Institute for Wealth Management LLC., Tower Research Capital LLC TRC , Bank of America Corp DE, Boston Research & Management Inc., Murphy Capital Management Inc., Aspiriant LLC and Advisor Group Inc.. Which institutional investors are buying VanEck Vectors Biotech ETF stock? BBH stock was bought by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Raymond James Financial Services Advisors Inc., Ironsides Asset Advisors LLC, Raymond James & Associates, Tufton Capital Management, Bailard Inc., Cypress Capital Group and Howard Wealth Management LLC. How do I buy shares of VanEck Vectors Biotech ETF? Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is VanEck Vectors Biotech ETF's stock price today? One share of BBH stock can currently be purchased for approximately $143.22. MarketBeat Community Rating for VanEck Vectors Biotech ETF (NASDAQ BBH)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 37 (Vote Outperform)Underperform Votes: 37 (Vote Underperform)Total Votes: 74MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Biotech ETF and other stocks. Vote "Outperform" if you believe BBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BBH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/16/2020 by MarketBeat.com StaffFeatured Article: What member countries make up the G-20?
